Back
Brainstorm Cell Therapeutics Vs. Apogee Enterprises Industry Stock Comparison
Sell
30
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.35
Seasonality Move:
27.17%
Sell
49
APOG
Apogee Enterprises
Last Price:
61.66
Seasonality Move:
1.82%
Sell
30
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $0.36. The Score for BCLI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Apogee Enterprises (APOG)
is a Sell
Is Apogee Enterprises a Buy, Sell or Hold?
- The current Apogee Enterprises [APOG] share price is $61.72. The Score for APOG is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- APOG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $0.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight buying pressure.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $61.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing selling pressure, which indicates risk of future bearish movement.
BCLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 37.85 | Sell |
Chaikin Money Flow: | 199201 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.38 - 0.48) | Sell |
Bollinger Bands (100): | (0.35 - 0.57) | Sell |
APOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 47.91 | Sell |
Chaikin Money Flow: | -255027 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.63 - 64.47) | Sell |
Bollinger Bands (100): | (56.39 - 63.89) | Buy |
BCLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.38 | Sell |
20-day SMA: | 0.41 | Sell |
50-day SMA: | 0.46 | Sell |
200-day SMA: | 0.38 | Sell |
8-day EMA: | 0.38 | Sell |
20-day EMA: | 0.41 | Sell |
50-day EMA: | 0.45 | Sell |
200-day EMA: | 0.66 | Sell |
APOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.17 | Buy |
20-day SMA: | 61.78 | Sell |
50-day SMA: | 63.27 | Sell |
200-day SMA: | 54.28 | Buy |
8-day EMA: | 61.72 | Sell |
20-day EMA: | 62.09 | Sell |
50-day EMA: | 62.03 | Sell |
200-day EMA: | 56.12 | Buy |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.02 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.67 per share, and an increase next year of $0.11 per share.
Brainstorm Cell Therapeutics Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apogee Enterprises Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |